| Net Cash Provided by (Used in) Operating Activities |
$56,407 |
USD |
-201% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$68,000 |
USD |
70% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$12,000 |
USD |
0% |
Q2 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
1,000,000,000 |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Common Stock, Shares, Issued |
99,790,810 |
shares |
2.6% |
Q3 2025 |
Q2 2026 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q3 2025 |
Q2 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$407 |
USD |
-104% |
Q2 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$2,336,800 |
USD |
2.5% |
Q1 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$2,336,800 |
USD |
2.5% |
Q1 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$2,177,800 |
USD |
4.1% |
Q1 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q2 2026 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Additional Paid in Capital |
$12,750,379 |
USD |
0.37% |
Q3 2025 |
Q2 2026 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q2 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q1 2025 |
FY 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q3 2025 |
Q2 2026 |